You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ROCEPHIN W Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rocephin W patents expire, and when can generic versions of Rocephin W launch?

Rocephin W is a drug marketed by Hoffmann La Roche and is included in one NDA.

The generic ingredient in ROCEPHIN W is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rocephin W

A generic version of ROCEPHIN W was approved as ceftriaxone sodium by ANDA REPOSITORY on January 20th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ROCEPHIN W?
  • What are the global sales for ROCEPHIN W?
  • What is Average Wholesale Price for ROCEPHIN W?
Summary for ROCEPHIN W
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:ROCEPHIN W at DailyMed
Drug patent expirations by year for ROCEPHIN W

US Patents and Regulatory Information for ROCEPHIN W

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-001 Feb 11, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-002 Feb 11, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-003 Feb 11, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.